A novel kind of food known as cell-cultivated products (CCPs) is produced without the need of conventional farming techniques like raising cattle or cultivating crops and grains.
Their seeming sustainability—they don’t require large quantities of land, and the greenhouse gas emissions from animals are reduced—attracts investors and consumers alike.
With the assistance of science and technology, cells from plants or animals are cultivated in a controlled environment to generate the new product.
In the UK, no CCPs are presently authorized for ingestion by humans.
In announcing the money, the FDA stated that in order to ensure that the items are safe for consumers to consume, it needed to learn “about these products and how they’re made.”
With the use of this data, we will be able to address issues that need to be resolved before any CCPs can be put on the market and provide well-informed, timely science and evidence-based recommendations for product safety.
Additionally, it will enable us to better advise businesses on how to produce goods in a safe manner and how to prove this to us.
